Bioactive human recombinant tumor necrosis factor-α: an unstable dimer?
- 1 October 1989
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 19 (10), 1887-1894
- https://doi.org/10.1002/eji.1830191020
Abstract
As determined by native polyacrylamide gel electrophoresis (PAGE) and gel chromatography the molecular mass of native tumor necrosis factor (TNF)-α was approximately 35 kDa. When incubated at low concentrations (< 1 nM) 125I-labeled TNF-α and unlabeled TNF-α rapidly multimerized or dissociated into monomers and bioactivity decreased. Sodium dodecyl sulfate (SDS)-PAGE analysis of cross-linked 125I-labeled TNF-α demonstrated bands of multi- and trimeric TNF-α in addition to dominating bands of dimers and monomers. Tri-, di- and monomeric TNF-α were recovered from SDS-PAGE gels and allowed to renature. Of the original receptor-binding activity, 10%–15% was obtained with cross-linked TNF-α dimers, whereas none was recovered from preparations of trimeric TNF-α. Multimeric and monomeric TNF-α exhibited little or no binding activity, and cell-bound, cross-linked TNF-α which was dissociated from cellular binding sites was mainly dimeric. 125I-labeled TNF-α bound to lymphokine-activated killer (LAK) cells and binding kinetics were much similar (Kd approximately 100 pM) to those reported in other normal cell types. The number of receptors per LAK cell was approximately 4 × 103. Cross-linking of TNF-α to binding sites in U-937 and LAK cells yielded a receptor-ligand complex of about 80/90 kDa. At 37 °C, 125I-labeled TNF-α was rapidly internalized and degraded in L-929, U-937 and LAK cells. Degradation of ligand and recycling of receptors were blocked in the presence of methylamine. Methylamine significantly inhibited TNF-α-mediated cytolysis of L-929 cells and caused a quantitatively corresponding reduction in cellular TNF-α uptake, indicating that L-929 lysis was mediated by receptors.This publication has 40 references indexed in Scilit:
- IMMUNOLOGICAL REACTIVITY AND BIOACTIVITY OF TUMOUR NECROSIS FACTORThe Lancet, 1988
- Detection of Tumour Necrosis Factor from Lipopolysaccharide‐Stimulated Human Mononuclear Cells by Enzyme‐Linked Immunosorbent Assay and Cytotoxicity BioassayScandinavian Journal of Immunology, 1988
- Tumor necrosis factor and related cytotoxinsImmunology Today, 1987
- EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCERThe Lancet, 1987
- Demonstration of membrane receptors for human natural and recombinant 125I‐labeled tumor necrosis factor on HeLa cell clones and their role in tumor cell sensitivityEuropean Journal of Biochemistry, 1986
- Binding and Crosslinking of 125I-Labeled Recombinant Human Tumor Necrosis Factor to Cell Surface Receptors1The Journal of Biochemistry, 1986
- Tumour Necrosis Factor—an OverviewActa Medica Scandinavica, 1986
- Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.Proceedings of the National Academy of Sciences, 1985
- Lymphotoxin reduxImmunology Today, 1985
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975